Canary Funds Lists Staking-Based Injective ETF on Nasdaq

Canary Funds' staking-based Injective ETF has listed on Nasdaq, adding a U.S.-traded product that offers exposure to Injective (INJ) through an exchange-traded vehicle with staking.

The Canary Funds staking-based Injective ETF (INJC) is listed on Nasdaq. The product trades under the ticker INJC and combines access to INJ through an exchange-traded product with a staking mechanism.

Canary Funds' fund is identified as an ETF tied to INJ, and Nasdaq is the exchange named for its listing. Its stated format brings token exposure and staking together in a single exchange-traded product. The ticker INJC identifies that product on the exchange.

For U.S. readers, the listing adds a Nasdaq-traded route to Injective token exposure. The product's description pairs that exposure with staking, while its exchange-traded format provides the listed vehicle for INJ access. The listing centers on the fund's availability, its Nasdaq venue and its staking feature. The fund is listed on Nasdaq.